Evidence map›Paper›PMID 32690539›Full record

ArticleBMJ open2020

Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping review.

Ashley Marie Polhemus, Ronny Bergquist, Magda Bosch de Basea, Gavin Brittain, Sara Catherine Buttery, Nikolaos Chynkiamis, Gloria Dalla Costa, Laura Delgado Ortiz, Heleen Demeyer, Kirsten Emmert and 27 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Gait differences between COPD and healthy controls: systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evaluation of mobility recovery after hip fracture: a scoping review of randomized controlled studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pedometers and Accelerometers in Multiple Sclerosis: Current and New Applications.International journal of environmental research and public health · 2022
    Review
  18. Healthcare Providers' Knowledge of Value-Based Care in Germany: An Adapted, Mixed-Methods Approach.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Ashley Marie PolhemusEpidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zürich, Switzerland ashley.polhemus@uzh.ch.ORCID 0000-0002-5056-5785
Ronny BergquistDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Magda Bosch de BaseaBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Gavin BrittainDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield, UK.
Sara Catherine ButteryNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-9410-414X
Nikolaos ChynkiamisDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, Tyne and Wear, UK.
Gloria Dalla CostaDepartment of Neurology, San Raffaele Hospital, Milan, Italy.
Laura Delgado OrtizBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Heleen DemeyerDepartment of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Kirsten EmmertDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
Judith Garcia AymerichBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Heiko GassnerDepartment of Molecular Neurology, Erlangen University Hospital, Erlangen, Bayern, Germany.
Clint HansenDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
Nicholas HopkinsonNational Heart and Lung Institute, Imperial College London, London, UK.
Jochen KluckenDepartment of Molecular Neurology, Erlangen University Hospital, Erlangen, Bayern, Germany.
Felix KlugeMachine Learning and Data Analytics Lab, Department of Computer Science, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
Sarah KochBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Letizia LeocaniDepartment of Neurology, San Raffaele Hospital, Milan, Italy.
Walter MaetzlerDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.
M Encarna Micó-AmigoTranslational and Clinical Research Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, Newcastle upon Tyne, UK.
A Stefanie MikolaizakDepartment of Clinical Gerontology, Robert Bosch Hospital, Stuttgart, Baden-Württemberg, Germany.
Paolo PirainoDepartment of Research & Early Development Statistics, Bayer AG, Berlin, Germany.
Francesca SalisDepartment of Biomedical Sciences, University of Sassari, Sassari, Sardegna, Italy.
Christian SchlenstedtDepartment of Neurology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany.ORCID 0000-0002-3838-6848
Lars SchwickertDepartment of Clinical Gerontology, Robert Bosch Hospital, Stuttgart, Baden-Württemberg, Germany.
Kirsty ScottINSIGNEO Institute for in Silico Medicine, The University of Sheffield, Sheffield, Sheffield, UK.
Basil SharrackDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield, UK.
Kristin TaraldsenDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Thierry TroostersDepartment of Rehabilitation Sciences, KU Leuven, Leuven, Flanders, Belgium.
Beatrix VereijkenDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Ioannis VogiatzisDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, Tyne and Wear, UK.
Alison YarnallTranslational and Clinical Research Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, Newcastle upon Tyne, UK.
Claudia MazzaINSIGNEO Institute for in Silico Medicine, The University of Sheffield, Sheffield, Sheffield, UK.
Clemens BeckerDepartment of Clinical Gerontology, Robert Bosch Hospital, Stuttgart, Baden-Württemberg, Germany.
Lynn RochesterTranslational and Clinical Research Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, Newcastle upon Tyne, UK.
Milo Alan PuhanEpidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zürich, Switzerland.
Anja FreiEpidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zürich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdvances in wearable sensor technology now enable frequent, objective monitoring of real-world walking. Walking-related digital mobility outcomes (DMOs), such as real-world walking speed, have the potential to be more sensitive to mobility changes than traditional clinical assessments. However, it is not yet clear which DMOs are most suitable for formal validation. In this review, we will explore the evidence on discriminant ability, construct validity, prognostic value and responsiveness of walking-related DMOs in four disease areas: Parkinson's disease, multiple sclerosis, chronic obstructive pulmonary disease and proximal femoral fracture. METHODS AND ANALYSIS: Arksey and O'Malley's methodological framework for scoping reviews will guide study conduct. We will search seven databases (Medline, CINAHL, Scopus, Web of Science, EMBASE, IEEE Digital Library and Cochrane Library) and grey literature for studies which (1) measure differences in DMOs between healthy and pathological walking, (2) assess relationships between DMOs and traditional clinical measures, (3) assess the prognostic value of DMOs and (4) use DMOs as endpoints in interventional clinical trials. Two reviewers will screen each abstract and full-text manuscript according to predefined eligibility criteria. We will then chart extracted data, map the literature, perform a narrative synthesis and identify gaps. ETHICS AND DISSEMINATION: As this review is limited to publicly available materials, it does not require ethical approval. This work is part of Mobilise-D, an Innovative Medicines Initiative Joint Undertaking which aims to deliver, validate and obtain regulatory approval for DMOs. Results will be shared with the scientific community and general public in cooperation with the Mobilise-D communication team. REGISTRATION: Study materials and updates will be made available through the Center for Open Science's OSFRegistry (https://osf.io/k7395).

Indexed as

Research DesignWalkingHumansScoping Reviews as Topicchronic airways diseasegeriatric medicinemultiple sclerosisorthopaedic & trauma surgeryParkinson-s diseasetelemedicine

Identifiers

PMID32690539
PMCPMC7371223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.